Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic issues in anti-retroviral therapy.

R Yarchoan1, H Mitsuya, S Broder

  • 1National Cancer Institute, Bethesda, MD 20892.

Immunology Today
|September 1, 1990
PubMed
Summary

Antiviral drugs can improve immune function in HIV patients by inhibiting viral replication. However, current therapies do not fully restore immunity in established AIDS cases, necessitating further research for enhanced treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.

Oncogene·2017
Same author

Molecular and cellular analyses of HLA class II-associated susceptibility to autoimmune diseases in the Japanese population.

Modern rheumatology·2014
Same author

PDK1 inhibition is a novel therapeutic target in multiple myeloma.

British journal of cancer·2013
Same author

Effect of translocation defective reverse transcriptase inhibitors on the activity of N348I, a connection subdomain drug resistant HIV-1 reverse transcriptase mutant.

Cellular and molecular biology (Noisy-le-Grand, France)·2013
Same author

The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.

Cellular and molecular biology (Noisy-le-Grand, France)·2011
Same author

PU.1 induces apoptosis in myeloma cells through direct transactivation of TRAIL.

Oncogene·2009

Area of Science:

  • Virology
  • Immunology
  • Pharmacology

Background:

  • Antiretroviral drugs targeting viral replication show efficacy against HIV in vitro and in vivo.
  • Inhibition of human immunodeficiency virus (HIV) replication correlates with improved immune function in infected individuals.
  • Established Acquired Immunodeficiency Syndrome (AIDS) patients often do not achieve complete immune reconstitution with existing therapies.

Purpose of the Study:

  • To review the effectiveness of current anti-HIV therapies.
  • To identify factors limiting complete immune recovery in patients with established AIDS.
  • To inform the development of more effective therapeutic strategies.

Main Methods:

  • Literature review of antiviral drug efficacy in HIV treatment.
  • Analysis of factors influencing immunologic improvement in HIV-infected patients.
  • Synthesis of current understanding of HIV replication and immune response.

Main Results:

  • Several drugs effectively inhibit HIV replication at various stages.
  • Viral replication inhibition leads to measurable improvements in immune function.
  • Complete immune reconstitution remains a challenge in patients with advanced AIDS.

Conclusions:

  • Current antiretroviral therapies improve immune function but do not fully restore it in established AIDS.
  • Understanding the limitations of current treatments is crucial for developing next-generation HIV therapies.
  • Further research is needed to overcome barriers to complete immunoreconstitution in advanced HIV disease.

Related Experiment Videos